Lineage Cell Therapeutics
Lineage is a clinical-stage biotechnology company developing novel cell therapies
Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.
Visit website: https://lineagecell.com/
People at Lineage Cell Therapeutics
Lineage Cell Therapeutics News
Longevity Technology interviews Lineage's CEO on the role of cell therapy in improving human longevity
Longevity Technology - 03-Aug-2023
Details magic of converting stem cells to any cell type and transplanting them to treat age-related conditionsRead more...
RPE-Cell therapy might potentially prevent blindness in dry AMD
Biospace - 14-Jun-2021
Lineage CEO says “it offers a whole new paradigm to treat the disease”Read more...
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting yearRead more...
Method of Generating Induced Pluripotent Stem Cells
Longevity Technology - 10-Dec-2019
New reprogramming technology could provide an alternate source of material needed for therapiesRead more...